Close
Nordic 9Nordic 9

Rick Klausner (investor - Angel Investor)

United States
See something wrong or missing? Let us know

Dr. Rick Klausner is knoown as former director of the US National Cancer Institute and former Executive Director of Global Health at the Bill & Melinda Gates Foundation

Average round investment:44.25M USD
Average number per year:1.0
Distribution: 2021 (1)2020 (1)
Portfolio companies: Netherlands MeatableUnited Kingdom bit.bio
Mostly invests in: Netherlands Netherlands (1) Food Industry (1)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Rick Klausner

Name Criteria
Canada Inovia Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Software Services, Competitive Intelligence, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Evotec AG
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Software Services, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Netherlands Thuja Capital Management B.V.
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Kathaka
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Software Services, Competitive Intelligence
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Honeywell Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Software Services, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Halma plc
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Food Industry, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: Netherlands, United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Lowercase Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Food Industry, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
France AXA IM
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Food Industry, Manufacturing, Software Services, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United States Data Collective (DCVC)
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Food Industry, Manufacturing, Biotech, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United Kingdom Isomer Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Software Services, Competitive Intelligence, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Top